Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank75
3Y CAGR+25.6%
5Y CAGR-6.6%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+25.6%/yr
vs +41.0%/yr prior
5Y CAGR
-6.6%/yr
Recent acceleration
Acceleration
-15.4pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.31 | -36.1% |
| 2024 | 2.06 | +260.5% |
| 2023 | 0.57 | -14.1% |
| 2022 | 0.66 | -37.3% |
| 2021 | 1.06 | -42.7% |
| 2020 | 1.85 | -59.7% |
| 2019 | 4.59 | +2630.6% |
| 2018 | 0.17 | -5.2% |
| 2017 | 0.18 | - |
| 2016 | 0.00 | - |